Your browser doesn't support javascript.
loading
The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 Diabetes.
Herring, Roselle A; Shojaee-Moradie, Fariba; Stevenage, Mary; Parsons, Iain; Jackson, Nicola; Mendis, Jeewaka; Middleton, Benita; Umpleby, A Margot; Fielding, Barbara A; Davies, Melanie; Russell-Jones, David L.
Affiliation
  • Herring RA; Centre for Endocrinology, Diabetes and Research, Royal Surrey NHS Foundation Trust, Guildford, U.K.
  • Shojaee-Moradie F; Faculty of Health and Medical Sciences, University of Surrey, Guildford, U.K.
  • Stevenage M; Centre for Endocrinology, Diabetes and Research, Royal Surrey NHS Foundation Trust, Guildford, U.K.
  • Parsons I; Centre for Endocrinology, Diabetes and Research, Royal Surrey NHS Foundation Trust, Guildford, U.K.
  • Jackson N; Centre for Endocrinology, Diabetes and Research, Royal Surrey NHS Foundation Trust, Guildford, U.K.
  • Mendis J; Faculty of Health and Medical Sciences, University of Surrey, Guildford, U.K.
  • Middleton B; Faculty of Health and Medical Sciences, University of Surrey, Guildford, U.K.
  • Umpleby AM; Faculty of Health and Medical Sciences, University of Surrey, Guildford, U.K.
  • Fielding BA; Faculty of Health and Medical Sciences, University of Surrey, Guildford, U.K.
  • Davies M; Faculty of Health and Medical Sciences, University of Surrey, Guildford, U.K.
  • Russell-Jones DL; Diabetes Research Centre, University of Leicester, Leicester, U.K.
Diabetes Care ; 45(6): 1408-1415, 2022 06 02.
Article in En | MEDLINE | ID: mdl-35312749

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials Limits: Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials Limits: Humans Language: En Year: 2022 Type: Article